VCI Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
24,261
+8,632
+55% +$691K 0.42% 55
2025
Q4
$1.49M Buy
15,629
+2,744
+21% +$269K 0.41% 64
2025
Q3
$1.26M Buy
+12,885
New +$1.33M 0.38% 66

Other funds holding BSX

VCI Wealth Management's BSX Position: Q1 2026 in Review

VCI Wealth Management increased its Boston Scientific (BSX) stake by 55% in Q1 2026, buying an estimated $691K and bringing the position to 24,261 shares worth $1.52M. The position accounts for 0.42% of the portfolio, ranked #55.

VCI Wealth Management first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • VCI Wealth Management held 24,261 shares of Boston Scientific worth $1.52M as of Q1 2026.
  • VCI Wealth Management bought 8,632 Boston Scientific shares in Q1 2026, an estimated $691K.
  • Boston Scientific made up 0.42% of VCI Wealth Management's portfolio in Q1 2026, its #55 holding.
  • VCI Wealth Management first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on VCI Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.